A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women

计划入组 40 人 · 首次发布于 2008 年 7 月 3 日

Effects of Activia in IBS

计划入组 100 人 · 首次发布于 2010 年 12 月 3 日

Activia Kefir Consumption in Real-world Setting

计划入组 550 人 · 首次发布于 2026 年 8 月 27 日

Sotatercept(Winrevair)

ActRIIB-2.12

Acurita

aktiia SA

Switzerland

Antria, Inc.

United States

Atridia Pty Ltd.

Australia

AliveGen's ALG-801 Demonstrates Superior Efficacy Over Standard PAH Therapies in Preclinical Studies

Laekna's LAE102 Shows Promising Safety Profile in First-in-Human Obesity Trial at ADA 2025

AliveGen's ALG-801 Receives FDA Orphan Drug Designation for Pulmonary Arterial Hypertension